Relocation of truncated bid plays an important role in suppression of tumor necrosis factor alpha induced apoptosis in hepatocytes isolated from transgenic mouse

J Surg Res. 2005 Aug;127(2):157-63. doi: 10.1016/j.jss.2005.03.007.

Abstract

Background/aims: Tumor necrosis factor alpha (TNFalpha) induces apoptosis in murine hepatocytes pretreated with Actinomycin D (ActD) in vitro. This study sought to clarify the relationship between hepatic energy status and TNFalpha-induced hepatocyte apoptosis, using mice transgenic for creatine kinase (CK) expression.

Materials and methods: Hepatocytes from CK transgenic mice were cultured with or without creatine (Cr). The concentrations of ATP and phosphocreatine (PCr) in hepatocytes were measured by high-pressure liquid chromatography. Sixteen hours after treatment with ActD and TNFalpha, we evaluated cell viability of these hepatocytes. We examined truncated Bid and cytochrome c by immunoblot analysis.

Results: Six hours after cell isolation, the concentration of PCr in CK transgenic hepatocytes cultured with Cr increased to 8.23 +/- 0.01 microg/mg protein, while that of hepatocytes cultured without Cr was lower than 0.1 microg/mg protein. In hepatocytes cultured without Cr, ActD and TNFalpha treatment induced massive cell death, while hepatocytes cultured with Cr maintained greater than 80% viability. In CK transgenic hepatocytes cultured with Cr, truncated Bid relocation to mitochondria was highly suppressed, compared to CK transgenic hepatocytes cultured without Cr.

Conclusion: PCr accumulation may prevent TNFalpha-induced apoptosis in murine hepatocytes by suppression of truncated Bid targeting to mitochondria.

MeSH terms

  • Animals
  • Apoptosis / physiology*
  • BH3 Interacting Domain Death Agonist Protein
  • Carrier Proteins / metabolism*
  • Caspase 3
  • Caspases / metabolism
  • Cells, Cultured
  • Creatine / pharmacology
  • Creatine Kinase / metabolism
  • Cytochromes c / metabolism
  • Electrophysiology
  • Enzyme Activation / drug effects
  • Hepatocytes / drug effects*
  • Hepatocytes / physiology*
  • Mice
  • Mice, Transgenic
  • Mitochondria / metabolism
  • Mitochondria / physiology
  • Peptide Fragments / metabolism
  • Permeability
  • Phosphocreatine / metabolism
  • Protein Serine-Threonine Kinases / metabolism
  • Proto-Oncogene Proteins / metabolism
  • Proto-Oncogene Proteins c-akt
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Tissue Distribution
  • Tumor Necrosis Factor-alpha / pharmacology*
  • bcl-X Protein

Substances

  • BH3 Interacting Domain Death Agonist Protein
  • Bcl2l1 protein, mouse
  • Bid protein, mouse
  • Carrier Proteins
  • Peptide Fragments
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • Tumor Necrosis Factor-alpha
  • bcl-X Protein
  • Phosphocreatine
  • Cytochromes c
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-akt
  • Creatine Kinase
  • Casp3 protein, mouse
  • Caspase 3
  • Caspases
  • Creatine